|
Market Closed -
Nasdaq
16:00:00 2026-08-25 EDT
|
5-day change | 1st Jan Change | ||
| 27.37 USD | +6.79% |
|
-13.96% | - |
| 07:15am | LifeSci Capital Initiates Coverage on Apnimed With Outperform Rating, $50 Price Target | MT |
| 07:14am | Cantor Fitzgerald Initiates Coverage on Apnimed With Overweight Rating, $60 Price Target | MT |
| Market Cap | 1.42B 1.22B 1.14B 1.04B 1.97B 135B 1.99B 13.45B 5.24B 68.32B 5.33B 5.22B 226B | P/E 2026 * |
-107x | P/E 2027 * | -7.39x |
|---|---|---|---|---|---|
| Enterprise Value | 1.42B 1.22B 1.14B 1.04B 1.97B 135B 1.99B 13.45B 5.24B 68.32B 5.33B 5.22B 226B | EV / Sales 2026 * |
16.7x | EV / Sales 2027 * | 60.8x |
| Free-Float |
80.74% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +6.79% | ||
| 1 week | -13.96% | ||
| Current month | +9.48% |
| 1 week | 25.33 |  | 33.12 |
| 1 month | 16.12 | | 35.29 |
| Current year | 16.12 | | 35.29 |
| 1 year | 16.12 | | 35.29 |
| 3 years | 16.12 | | 35.29 |
| 5 years | 16.12 | | 35.29 |
| 10 years | 16.12 | | 35.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Barry Wohl
PRN | Corporate Officer/Principal | 42 | 2018-05-31 |
| Chief Executive Officer | 50 | 2026-06-01 | |
Luigi Montemurro
CTO | Chief Tech/Sci/R&D Officer | - | 2021-03-03 |
| Director | Title | Age | Since |
|---|---|---|---|
Lawrence Miller
CHM | Chairman | 73 | 2017-12-31 |
Joseph Avellone
BRD | Director/Board Member | 77 | 2017-05-31 |
| Director/Board Member | 46 | 2022-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/3/26 | Issuer sale | Director | -281,688 | 0.7072% | ||
| 8/3/26 | Issuer sale | Chairperson | -1,499,492 | 3.7648% | ||
| 8/3/26 | Issuer sale | Chief Executive Officer | -2,738,644 | 6.8760% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.79% | -13.96% | - | - | 1.42B | |
| +1.02% | +4.84% | +4.80% | +24.36% | 51.21B | |
| -0.09% | -2.14% | +492.60% | +537.84% | 45.35B | |
| -0.32% | +8.08% | +37.97% | +18.45% | 42.84B | |
| +1.18% | +1.96% | +21.95% | +89.69% | 42.29B | |
| -2.27% | -5.67% | +14.55% | +50.34% | 32.15B | |
| -0.96% | +4.03% | +31.55% | +136.34% | 17.31B | |
| +0.41% | +1.66% | - | - | 16.55B | |
| +1.12% | +5.83% | +8.37% | +32.33% | 14.84B | |
| -0.31% | +6.61% | +81.37% | +48.53% | 14.25B | |
| Average | +0.68% | +0.62% | +86.64% | +117.24% | 27.82B | |
| Weighted average by Cap. | +0.13% | +2.77% | +105.43% | +135.92% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 84.94M 72.78M 68.2M 62.3M 118M 8.1B 119M 804M 313M 4.09B 319M 312M 13.53B | 23.35M 20.01M 18.75M 17.12M 32.32M 2.23B 32.64M 221M 86.09M 1.12B 87.67M 85.76M 3.72B |
| Net income | -11.13M -9.54M -8.94M -8.16M -15.41M -1.06B -15.56M -105M -41.04M -535M -41.79M -40.88M -1.77B | -172M -148M -138M -126M -238M -16.42B -241M -1.63B -635M -8.28B -647M -633M -27.43B |
| Net Debt | - | - |
Employees
65
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-25 | US$27.37 | +6.79% | 480,426 |
| 26-08-24 | US$25.63 | -8.56% | 244,556 |
| 26-08-21 | US$28.03 | -1.82% | 246,332 |
| 26-08-20 | US$28.55 | -10.86% | 433,782 |
| 26-08-19 | US$32.03 | +0.69% | 132,634 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- APMD Stock
Select your edition
All financial news and data tailored to specific country editions
